These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34761976)

  • 1. An opt-out approach to hepatitis C virus testing in English prisons: the literature underpinning the policy.
    Jack K
    Br J Nurs; 2021 Nov; 30(20):1158-1164. PubMed ID: 34761976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing.
    Perrett SE; Plimmer A; Shankar AG; Craine N
    J Public Health (Oxf); 2020 May; 42(2):423-428. PubMed ID: 32090269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do people in prison feel about opt-out hepatitis C virus testing?
    Jack K; Linsley P; Thomson BJ; Irving WL
    J Viral Hepat; 2020 Oct; 27(10):1003-1011. PubMed ID: 32488916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for hepatitis C virus infection in UK prisons: What actually happens?
    Jack K; Thomson BJ; Irving WL
    J Viral Hepat; 2019 Jun; 26(6):644-654. PubMed ID: 30702194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.
    Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Brixko C; Laukens P; Orlent H; Bilaey P; De Smet F; Hellemans G; Muyldermans G; Van Baelen L; Hens N; Van Vlierberghe H; Robaeys G
    BMC Infect Dis; 2021 Jul; 21(1):708. PubMed ID: 34315415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine testing for blood-borne viruses in prisons: a systematic review.
    Rumble C; Pevalin DJ; O'Moore É
    Eur J Public Health; 2015 Dec; 25(6):1078-88. PubMed ID: 26219884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare professional stakeholders.
    Ruiz AS; Fontaine G; Patey AM; Grimshaw JM; Presseau J; Cox J; Dussault C; Kronfli N
    Int J Drug Policy; 2022 Nov; 109():103837. PubMed ID: 36030569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus recommendations on the management of hepatitis C in Australia's prisons.
    Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ
    Med J Aust; 2023 Mar; 218(5):231-237. PubMed ID: 36871200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.
    Francis-Graham S; Ekeke NA; Nelson CA; Lee TY; Haj SE; Rhodes T; Vindrola C; Colbourn T; Rosenberg W
    BMC Health Serv Res; 2019 Mar; 19(1):152. PubMed ID: 30849986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
    Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
    Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constructing a middle-range theory to explain the uptake of hepatitis C tests in prison.
    Jack K; Linsley P
    Nurse Res; 2021 Jun; 29(2):33-40. PubMed ID: 33733646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
    Irvin R; Landry G; Jones MR; James A; Schexnayder J; Rodriguez S; Wendell D; Barthe K; Britton E; LeSar K; Manogue S; Sugarman OK; Brown C; Burgess S; Mehta SH; Thomas DL; Robinson W;
    J Viral Hepat; 2024 Jul; 31(7):432-435. PubMed ID: 38758571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.
    Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
    BMC Public Health; 2020 Nov; 20(1):1670. PubMed ID: 33167912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on Integrated HIV and Hepatitis C Virus Testing Among Persons Entering a Northern California Jail: A Pilot Study.
    Ly W; Cocohoba J; Chyorny A; Halpern J; Auerswald C; Myers J
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):214-220. PubMed ID: 29474267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review.
    Kronfli N; Linthwaite B; Kouyoumdjian F; Klein MB; Lebouché B; Sebastiani G; Cox J
    Int J Drug Policy; 2018 Jul; 57():95-103. PubMed ID: 29715590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
    Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
    J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.
    de la Flor C; Porsa E; Nijhawan AE
    Public Health Rep; 2017; 132(6):617-621. PubMed ID: 29045799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
    Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
    Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016.
    Assoumou SA; Wang J; Tasillo A; Eftekhari Yazdi G; Tsui JI; Strick L; Linas BP
    Am J Prev Med; 2019 Jan; 56(1):8-16. PubMed ID: 30467088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.